EUVIMEDEUVIMED entdecken
Open Access

Microparticle Mediated Delivery of Apelin Improves Heart Function in Post Myocardial Infarction Mice

Ling Tang iD, Huiliang Qiu iD, Bing Xu, Yajuan Su iD, Verah Nyarige iD, Pengsheng Li iD, Houjia Chen, Brady Killham, Jun Liao iD, Henderson Adam iD, Aaron Yang iD, Alexander Yu iD und 4 weitere

Circulation Research · 13.09.2024 · 135 (7) · 777-798

DOI: 10.1161/circresaha.124.324608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, erschienen am 13.09.2024. Verfasst von Ling Tang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Diseases, Physiology and Biomedical Engineering, Center for Regenerative Medicine, Mayo Clinic Arizona, Scottsdale (L.T.…. Hauptthemen laut MEDLINE: Apelin, Myocardial Infarction. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Apelin is an endogenous prepropeptide that regulates cardiac homeostasis and various physiological processes. Intravenous injection has been shown to improve cardiac contractility in patients with heart failure. However, its short half-life prevents studying its impact on left ventricular remodeling in the long term. Here, we aim to study whether microparticle-mediated slow release of apelin improves heart function and left ventricular remodeling in mice with myocardial infarction (MI). METHODS: A cardiac patch was fabricated by embedding apelin-containing microparticles in a fibrin gel scaffold. MI was induced via permanent ligation of the left anterior descending coronary artery in adult C57BL/6J mice followed by epicardial patch placement immediately after (acute MI) or 28 days (chronic MI) post-MI. Four groups were included in this study, namely sham, MI, MI plus empty microparticle-embedded patch treatment, and MI plus apelin-containing microparticle-embedded patch treatment. Cardiac function was assessed by transthoracic echocardiography. Cardiomyocyte morphology, apoptosis, and cardiac fibrosis were evaluated by histology. Cardioprotective pathways were determined by RNA sequencing, quantitative polymerase chain reaction, and Western blot. RESULTS: The level of endogenous apelin was largely reduced in the first 7 days after MI induction and it was normalized by day 28. Apelin-13 encapsulated in poly(lactic-co-glycolic acid) microparticles displayed a sustained release pattern for up to 28 days. Treatment with apelin-containing microparticle-embedded patch inhibited cardiac hypertrophy and reduced scar size in both acute and chronic MI models, which is associated with improved cardiac function. Data from cellular and molecular analyses showed that apelin inhibits the activation and proliferation of cardiac fibroblasts by preventing transforming growth factor-β–mediated activation of Smad2/3 (supporessor of mothers against decapentaplegic 2/3) and downstream profibrotic gene expression. CONCLUSIONS: Poly(lactic-co-glycolic acid) microparticles prolonged the apelin release time in the mouse hearts. Epicardial delivery of the apelin-containing microparticle-embedded patch protects mice from both acute and chronic MI-induced cardiac dysfunction, inhibits cardiac fibrosis, and improves left ventricular remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApelinMyocardial InfarctionAnimalsMaleMiceApoptosisDisease Models, AnimalFibrosisMice, Inbred C57BLMyocytes, CardiacVentricular Function, LeftVentricular Remodeling

Stichwörter der Autor:innen

animalsfibroblastsheart failuremicemyocardial infarction

Substanzen

ApelinApln protein, mouse

Autor:innen und Institutionen

  • Department of Cardiovascular Diseases, Physiology and Biomedical Engineering, Center for Regenerative Medicine, Mayo Clinic Arizona, Scottsdale (L.T., H.Q., B.X., V.N., P.L., H.A., A. Yang, A. Yu, M.J., W.Z.).
  • Department of Surgery-Transplant and Mary and Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha (Y.S., J.X.).
  • Department of Bioengineering, University of Texas at Arlington (H.C., B.K., J.L.).
  • Department of Pediatrics, Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis (M.R.).

ORCID-Profile: Ling Tang, Huiliang Qiu, Yajuan Su, Verah Nyarige, Pengsheng Li, Jun Liao, Henderson Adam, Aaron Yang, Alexander Yu, Michelle Jang, Michael Rubart, Jingwei Xie, Wuqiang Zhu

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Tang, L., Qiu, H., Xu, B., Su, Y., Nyarige, V., Li, P., Chen, H., Killham, B., Liao, J., Adam, H., Yang, A., Yu, A., Jang, M., Rubart, M., Xie, J., & Zhu, W. (2024). Microparticle Mediated Delivery of Apelin Improves Heart Function in Post Myocardial Infarction Mice. Circulation Research, 135(7), 777-798. https://doi.org/10.1161/circresaha.124.324608

Vancouver

Tang L, Qiu H, Xu B, Su Y, Nyarige V, Li P, et al. Microparticle Mediated Delivery of Apelin Improves Heart Function in Post Myocardial Infarction Mice. Circulation Research. 2024;135(7):777-798. doi:10.1161/circresaha.124.324608

BibTeX
@article{Tang2024,
  author = {Tang, Ling and Qiu, Huiliang and Xu, Bing and Su, Yajuan and Nyarige, Verah and Li, Pengsheng and Chen, Houjia and Killham, Brady and Liao, Jun and Adam, Henderson and Yang, Aaron and Yu, Alexander and Jang, Michelle and Rubart, Michael and Xie, Jingwei and Zhu, Wuqiang},
  title = {Microparticle Mediated Delivery of Apelin Improves Heart Function in Post Myocardial Infarction Mice},
  journal = {Circulation Research},
  year = {2024},
  volume = {135},
  number = {7},
  pages = {777--798},
  doi = {10.1161/circresaha.124.324608}
}
Kostenlos starten →